Antipsychotic drug doses and neuroleptic/dopamine receptors

[1]  P. Seeman,et al.  Brain receptors for antipsychotic drugs and dopamine: direct binding assays. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Snyder,et al.  Dopamine receptor binding in the corpus striatum of mammalian brain. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. Snyder,et al.  Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol. , 1975, Life sciences.

[4]  O Kennard,et al.  Dopamine receptor blockade and the neuroleptics, a crystallographic study , 1975, The Journal of pharmacy and pharmacology.

[5]  P. Seeman,et al.  Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. , 1975, Science.

[6]  L. Iversen.  Dopamine receptors in the brain. , 1975, Science.

[7]  P. Seeman,et al.  The nerve impulse-blocking actions of tranquilizers and the binding of neuroleptics to synaptosome membranes. , 1974, The Journal of pharmacology and experimental therapeutics.

[8]  G. Simpson,et al.  An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia. , 1974, Current therapeutic research, clinical and experimental.

[9]  G. Caillé,et al.  Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics. , 1973, Current therapeutic research, clinical and experimental.

[10]  S. Curry,et al.  Physiologic and clinical effects of chlorpromazine and their relationship to plasma level , 1972, Clinical pharmacology and therapeutics.